Macular Degeneration Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults over 18 years old (male or female) who have been diagnosed with wet (exudative) age-related macular degeneration (AMD), a condition where abnormal blood vessels grow under the retina
- People whose treating doctor considers gene therapy to be a possible option for their care
Who may not be able to join:
- People who have dry (atrophic) AMD, which is a different form of age-related macular degeneration
- People who have other retinal diseases that cause the eye to deteriorate, where these conditions are separate from AMD
- People who have cognitive difficulties or disorders affecting memory and thinking
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +33 2 53 48 28 57
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The experience and current treatment outcomes perceived by patients
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.